Using computer simulations to compare pertussis vaccination strategies in Australia

Vaccine

Volumn 22, Issue 17-18, 2004, Pages 2181-2191

  Hethcote, Herbert W ^a   Horby, Peter ^b,c   McIntyre, Peter ^c  

^a UNIVERSITY OF IOWA   (United States)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Adolescent; Pertussis; Vaccination

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; CHILD; COMPUTER SIMULATION; DISEASE TRANSMISSION; DOSE RESPONSE; EPIDEMIOLOGICAL DATA; HUMAN; INFANT; NEWBORN; PERTUSSIS; PREDICTION; PRIORITY JOURNAL; TREATMENT PLANNING; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; AUSTRALIA; BORDETELLA PERTUSSIS; CHILD; COMPUTER SIMULATION; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; PERTUSSIS VACCINE; VACCINATION; WHOOPING COUGH;

EID: 2442555060     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.11.053     Document Type: Article

References (48)

1. Cordova S.P., Gilles M.T., Beers M.Y. The outbreak that had to happen: Bordetella pertussis in north-west western Australia in 1999. Commun. Dis. Intell. 24:2000;375-379
2. McIntyre P, Gidding H, Gilmour R, Lawrence G, Hull B, Horby P, et al. National Centre for Immunization Research and Surveillance of Vaccine Preventable Diseases. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000. Commun Dis Intell 2002;(Suppl i-xi):1-111. http://www.health.gov.au/pubhlth/cdi/pubs/pdf/vpd99_00.pdf.
3. Guris D., Strebel P.M., Bardenheier B., Brennan M., Tachdjian R., Finch E., et al. Changing epidemiology of pertussis in the United States: increased reported incidence among adolescents and adults, 1990-1996. Clin. Infect. Dis. 28:1999;1230-1237
4. Strebel P., Nordin J., Edwards K., Hunt J., Besser J., Burns S., et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J. Infect. Dis. 183:2001;1353-1359
5. Yih W.K., Lett S.M., des Vignes F.N., Garrison K.M., Sipe P.L., Marchant C.D. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J. Infect. Dis. 182:2000;1409-1416
6. Centers for Disease Control and Prevention. Pertussis-United States, 1997-2000. Morbidity Mortality Weekly Rep 2002;51(4):73-6.
7. Mink C.A.M., Cherry J.D., Christenson P., Lewis K., Pineda E., Shlian D., et al. A search for Bordetella pertussis infection in university students. Clin. Infect. Dis. 14:1992;464-471
8. Long S.S., Welkon C.J., Clark J.L. Widespread silent transmission of pertussis in families: antibody correlations of infection and symptomatology. J. Infect. Dis. 161:1990;480-486
9. Wright S.W., Edwards K.M., Decker M.D., Zeldin M.H. Pertussis infection in adults with persistent cough. J. Am. Med. Assoc. 273:1995;1044-1046
10. Nenning M.E., Shinefield H.R., Edwards K.M., Black S.B., Fireman B.H. Prevalence and incidence of adult pertussis in an urban population. J. Am. Med. Assoc. 275:1996;1672-1674
11. De Serres G., Shadmani R., Duval B., Boulianne N., Déry P., Fradet M.D., et al. Morbidity of pertussis in adolescents and adults. J. Infect. Dis. 182:2000;74-79
12. Thomas P.F., McIntyre P.B., Jalaludin B.B. Survey of pertussis in adults in western Sydney. Med. J. Aust. 173:2000;74-76
13. Cherry J.D. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin. Infect. Dis. 28:1999;S112-S117
14. Edwards K.M., Decker M.D., Graham B.S., Mezzatesta J., Scott J., Hackell J. Adult immunization with acellular pertussis vaccine. J. Am. Med. Assoc. 269:1993;53-56
15. Deen J.L., Mink C.A.M., Cherry J.D., Christenson P.D., Pineda E.F., Lewis K., et al. Household contact study of Bordetella pertussis infections. Clin. Infect. Dis. 21:1995;1211-1219
16. Farizo K.M., Cochi S.L., Zell E.R., Brink E.W., Wassilak S.G., Patriarca P.A., et al. Epidemiological features of pertussis in the United States, 1980-1989. Clin. Infect. Dis. 14:1992;708-719
17. Deville J.G., Cherry J.D., Christenson P.D., Pineda E., Leach C.T., Kuhls T.L., et al. Frequency of unrecognized Bordetella pertussis infections in adults. Clin. Infect. Dis. 21:1995;639-642
18. He Q., Viljanen M.K., Nikkari S., Lyytikainen R., Mertsola J. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. J. Infect. Dis. 170:1994;873-877
19. van Boven M., de Melker H.E., Schellekens J.F., Kretzschmar M. Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. Math. Biosci. 164:2000;161-182
20. Campins-Marti M., Cheung H.K., Forsyth K., Guiso N., Halperin S., Huang L.-M., et al. Recommendations are needed for adolescent and adult pertussis immunization: rationale and strategies for consideration. Vaccine. 20:2002;641-646
21. Greco M.D., Salmaso D., Mastrantonio P., Giulianno M., Tozzi A., Anemona A., et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med. 334:1996;341-348
22. Trollfors B., Taranger J., Lagergard T., Lind L., Sundh V., Zackrisson G., et al. A placebo-controlled trial of a pertussis-toxoid vaccine. N. Engl. J. Med. 333:1995;1045-1050
23. Gustafsson L., Hallander H.O., Olin P., Reizenstein E., Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med. 334:1996;349-355
24. Lugauer S., Heininger U., Cherry J.D., Stehr K. Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine. Eur. J. Pediatr. 161:2002;142-146
25. Salmaso S, Mastrantonio P, Tozzi AE, Stefanelli P, Anemona A, Ciofi ML, et al. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics 2001;108:e81. http://www.pediatrics.org/cgi/content/full/108/5/e81.
26. Halperin S.A., Smith B., Russell M., Hasselback P., Guasparini R., Skowronski D., et al. An adult formulation of a 5-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine. 18:2000;1312-1319
27. Turnbull F.M., Heath T.C., Jaluludin B.B., Burgess M.A., Ramalho A.C. A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults. Vaccine. 19:2000;628-636
28. Halperin SA. Pertussis immunization for adolescents: what are we waiting for? Paediatr Child Health 2001;6(4).
29. Grenfell B.T., Anderson R.M. Pertussis in England and Wales: an investigation of transmission dynamics and control by mass vaccination. Proc. R. Soc. London B. 236:1989;213-252
30. Rohani P., Earn D.J.D., Grenfell B.T. Opposite patterns of synchrony in sympatric disease metapopulations. Science. 286:1999;968-971
31. Edmunds W.J., Brisson M., Melegaro A., Gay N.J. The potential cost-effectiveness of acellular pertussis booster vaccination in England and Wales. Vaccine. 20:2002;1316-1330
32. Hethcote H.W. An age-structured model for pertussis transmission. Math. Biosci. 145:1997;89-136
33. Hethcote H.W. Oscillations in an endemic model for pertussis. Can. Appl. Math. Q. 6:1998;61-88
34. Hethcote H.W. Simulations of pertussis epidemiology in the United States: effects of adult booster vaccinations. Math. Biosci. 158:1999;47-73
35. Hethcote HW. New vaccination strategies for pertussis. In: Castillo-Chavez C, Blower S, van den Driessche P, Kirschner D, Yakubu AA, editors. Mathematical approaches for emerging and reemerging infectious diseases. Part I. An introduction to models, methods, and theory. Berlin: Springer-Verlag; 2001. p. 97-118.
36. Tomoda T., Ogura H., Kurashige T. Two primary doses of diphtheria-tetanus-acellular pertussis vaccine induce immunological responses to Bordetella pertussis as strong as those induced by three primary doses. Vaccine. 15:1997;1955-1958
37. Blennow M., Granstrom M. Adverse reactions and serologic response to a booster dose of acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine as infants. Pediatrics. 84(1):1989;62-67
38. Blennow M., Granstrom M. Long term serologic follow-up after pertussis immunization. Pediatr. Infect. Dis. J. 9(1):1990;21-26
39. Tindberg Y., Blennow M., Granstrom M. A ten year follow-up after immunization with a two component acellular pertussis vaccine. Pediatr. Infect. Dis. J. 18(4):1999;361-365
40. Chin J, editor. Control of communicable diseases manual. 17th ed. Washington, DC: American Public Health Association; 2000.
41. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press; 1991.
42. Brisson M., Edmunds W.J., Gay N.J., Law B., DeSerres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol. Infect. 125:2000;651-669
43. Edmunds W.J., Gay N.J., Kretzschmar M., Pebody R.G., Wachmann H. The pre-vaccination epidemiology of measles, mumps, and rubella in Europe: implications for modeling studies. Epidemiol. Infect. 125:2000;635-650
44. Grenfell B.T., Anderson R.M. The estimation of age related rates of infection from case notifications and serological data. J. Hyg. 95:1985;419-436
45. Anderson R.M., May R.M. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes. J. Hyg. Camb. 94:1985;365-436
46. Graydon J.J. Whooping-cough vaccination. Med. J. Aust. 15(33):1964;251-254
47. Jalaludin B., Chow C. Western Sydney survey of long day care centers April 1995: receipt of 4 DTP doses by age 2. NSW Public Health Bull. 7-10:1996;118
48. Edmunds W.J., Pebody R.G., Aggerback H., Baron S., Berbers G., Conyn-van Spaendonck A.E., et al. The sero-epidemiology of diphtheria in western Europe. ESEN project. European sero-epidemiology network. Epidemiol. Infect. 125:2000;113-125